Quantcast
Free Trial!
Today’s Best Stocks To Trade!  Click Here


 

DeCODE Discovers More Common Genetic Variants Linked To Estrogen Receptor-Positive Breast Cancer Risk - Quick Facts

Sunday, April 27, 2008; Posted: 01:57 PM
Stocks RSS
7 Stocks You Need To Know For Tomorrow -- Free Newsletter
(RTTNews) - Sunday, deCODE genetics (DCGN | news | PowerRating | PR Charts ) revealed that it has discovered two common single-letter variants on chromosome 5 of the human genome, which is related to estrogen receptor-positive breast cancer risk. The company noted that the second of the variants occurs only in tandem with the first, adding slight risk of the disease. However, these variants are so common that they are estimated to account for around 11% of breast cancers overall.

This discovery has elucidated the genetic factors underpinning a very significant proportion of inherited risk of ER+ breast cancer. The discovery was based on the analysis of genotypic data from a total of nearly 40 thousand patients and control subjects from five countries.

For comments and feedback: contact editorial@rttnews.com Copyright(c) 2008 RealTimeTraders.com, Inc. All Rights Reserved

For full details for DCGN click here.
Morning Coffee with TradingMarkets -- Free Newsletter

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.